Klaus Christian Schollmeier
Chairman at Embark Laboratories ApS
Network origin in Klaus Christian Schollmeier first degree
Entity | Entity type | Industry | |
---|---|---|---|
Embark Laboratories ApS
Embark Laboratories ApS BiotechnologyHealth Technology Embark Laboratories ApS is a Danish biotech company that focuses on cardiometabolic disease. The private company is based in Copenhagen, Denmark. The company was founded in 2023. Casper Tind Hansen has been the CEO of the company since 2023.
2
| Private Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Klaus Christian Schollmeier via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
H. LUNDBECK A/S | Pharmaceuticals: Major | Sales & Marketing | |
University of Copenhagen | College/University | Graduate Degree | |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Corporate Officer/Principal | |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
Embark Biotech ApS
Embark Biotech ApS Miscellaneous Commercial ServicesCommercial Services Novo Nordisk Research Center Gladsaxe ApS is based in Bagsværd, Denmark. The Danish company is a spin-out from the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) at the University of Copenhagen. The company discovered a novel target that suppresses appetite, increases energy expenditure, and enhances insulin sensitivity. The development of the target was initiated through a collaboration with Novo Nordisk and further matured with support from the Innobooster program at the Innovation Fund Denmark and the Bioinnovation Institute (BII) during a residency in the Venture House program. Part of Novo Nordisk A/S, Novo Nordisk Research Center Gladsaxe ApS is a biotech company that was founded in 2017. The CEO of the company is Casper Tind Hansen. Novo Nordisk Research Center Gladsaxe was acquired by Novo Nordisk A/S from Embark Laboratories ApS on August 28, 2023 for $68.06 million. | Miscellaneous Commercial Services | Chief Executive Officer | |
Churney ApS
Churney ApS Data Processing ServicesTechnology Services Churney ApS is a company based in Copenhagen, Denmark. The Danish company was founded by Casper Tind Hansen, Christian Hansen, Noy Rotbart, Brian Brost. Noy Rotbart has been the CEO of the company since 2021. | Data Processing Services | Founder |
Statistics
International
Denmark | 9 |
Sectoral
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Technology Services | 2 |
Operational
Director/Board Member | 5 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Sales & Marketing | 1 |
Graduate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Casper Hansen | 9 |
Jakob Bondo Hansen | 1 |
- Stock Market
- Insiders
- Klaus Christian Schollmeier
- Company connections